| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-37 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11B1-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11B1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11B1-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11B1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11B1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11B1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-074 |
| filingDate |
2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109331049-B |
| titleOfInvention |
New use of Ganoderma lucidum spore oil and/or pharmaceutical composition containing Ganoderma lucidum spore oil |
| abstract |
The invention discloses application of ganoderma lucidum spore oil and/or a pharmaceutical composition containing ganoderma lucidum spore oil in preparing functional food and medicines with the effect of preventing myocardial fibrosis caused by aortic valvular disease, and the invention discloses new application of ganoderma lucidum spore oil and/or a pharmaceutical composition containing ganoderma lucidum spore oil in preventing myocardial fibrosis caused by aortic valvular disease for the first time, and provides a new method for preventing myocardial fibrosis caused by aortic valvular disease. |
| priorityDate |
2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |